Shalby has announced the discontinuation of its SOCE (Surgery on Correct site and Correct patient Every time) activities at two of its facilities, marking a significant operational adjustment for the healthcare provider.

Operational Changes at Key Facilities

The company has ceased SOCE operations at its Rajkot and Lucknow facilities. This decision affects the specialized surgical protocols that were previously implemented at these locations as part of the company's comprehensive healthcare services.

Economic Factors Drive Decision

The primary reason cited for this operational change is economic unworkability. The company determined that continuing SOCE activities at these facilities was not financially sustainable, leading to the strategic decision to discontinue these services.

Impact on Service Portfolio

This development represents a focused approach by Shalby to streamline its operations based on economic viability. The discontinuation of SOCE activities at these specific locations indicates the company's commitment to maintaining financially sustainable operations while continuing to provide healthcare services through other protocols and procedures.

The decision reflects broader operational considerations as healthcare providers navigate the balance between specialized service offerings and economic sustainability in different markets.

Shalby Limited has strengthened its position in subsidiary PK Healthcare Private Limited (PKHPL) by increasing its shareholding from 87.26% to 91.13% through a rights issue completed on February 28, 2026. The healthcare company invested ₹59,60,19,500 to acquire additional equity shares, reinforcing its strategic presence in the Delhi/NCR healthcare market.

Rights Issue Details

The rights issue involved the allotment of 5,96,01,950 equity shares of face value ₹10 each at a price of ₹10 per share. The issue was offered to all existing shareholders in the ratio of 1 new equity share for every 2 existing equity shares held as on the record date of January 24, 2026.

Shareholding Changes

Following the rights issue completion, Shalby's shareholding in PKHPL has increased significantly, demonstrating the company's commitment to expanding its subsidiary operations.

The subsidiary's paid-up share capital post-allotment stands at 19,62,15,850 equity shares of ₹10 each, amounting to ₹196,21,58,500.

PK Healthcare Background and Performance

PK Healthcare Private Limited was acquired by Shalby in January 2024 as part of the company's strategy to accelerate its presence in the Delhi/NCR region. The acquisition aimed to scale up international business operations and deliver quality healthcare services in northern India.

The subsidiary has demonstrated consistent financial growth over the past three years:

Fund Utilization

The funds raised through the rights issue will be deployed for multiple strategic purposes to strengthen PKHPL's operational capabilities. The company has outlined the following utilization areas:

• Repayment of existing debt obligations
• Working capital requirements
• General corporate purposes

This capital infusion is expected to support the subsidiary's continued growth trajectory and enhance its ability to provide comprehensive and advanced medical facilities to patients in the northern region. The transaction represents Shalby's ongoing commitment to expanding its healthcare network and strengthening its market position through strategic investments in subsidiary operations.